hCG for Koi Fish: Uses, Spawning Support & Veterinary Supervision

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Human chorionic gonadotropin, or hCG, is a hormone sometimes used in fish medicine as a spawning aid. In koi and other finfish broodstock, it is used to help trigger final reproductive events such as ovulation in females or sperm release in males when the fish are already mature and close to spawning. It is not a routine pond medication, and it is not meant for general wellness, growth, or behavior problems.

In practice, hCG is usually given as an injection by or on the order of a licensed veterinarian. U.S. aquaculture references list chorionic gonadotropin products such as Chorulon for improving spawning function in male and female brood finfish, with intramuscular administration and veterinary restriction. Merck also notes that fish medicine increasingly includes procedures for reproductive problems, including failure to ovulate in fish. (fws.gov)

For pet parents, the key point is that hCG is highly situation-dependent. A koi that is not ready to spawn, is stressed, or is dealing with poor water quality may not respond well. Your vet will usually look at season, body condition, water temperature, handling stress, and whether the fish is truly reproductively mature before discussing hormone support. (merckvetmanual.com)

In koi, hCG is mainly used to support induced spawning in broodstock fish that are mature but not completing the spawning process on their own. That may include helping a female complete ovulation or helping a male produce milt for planned breeding. It is generally considered when environmental management alone has not been enough, or when a controlled breeding program needs more predictable timing.

This medication is not a first-line answer for every reproductive concern. A koi with abdominal swelling, lethargy, buoyancy changes, or failure to spawn may have several possible problems, including retained eggs, infection, fluid buildup, or non-reproductive disease. Because those signs overlap, your vet may recommend an exam, sedation for handling, imaging if available, and water-quality review before deciding whether hormone treatment is appropriate. Merck emphasizes that fish care decisions should account for diagnostics, therapeutic options, and water quality, and notes that surgery may be considered in some fish with failure to ovulate. (merckvetmanual.com)

It is also worth knowing that other spawning aids exist. In the U.S., OVAPRIM is currently listed by the FDA Index for use as a spawning aid in finfish broodstock, so your vet may discuss hCG as one option among several rather than the only path forward. The best choice depends on the breeding goal, the fish's maturity, prior response to hormones, and the practical realities of handling a large koi safely. (fda.gov)

There is no one-size-fits-all dose for koi. Published aquaculture references show broad chorionic gonadotropin dosing ranges for brood finfish, and the labeled U.S. quick-reference range for Chorulon is about 148-4,004 IU/kg for females and about 110-1,124 IU/kg for males when converted from the listed IU/lb guidance. Some species-specific fish breeding references also report lower or mid-range hCG protocols, which is one reason your vet should tailor the plan to the individual fish, sex, maturity stage, and breeding objective. (fws.gov)

In many cases, the more important question is not only how much, but when. Hormone response depends heavily on whether the koi is truly ready to spawn. Fish that are immature, debilitated, or stressed by transport, poor oxygenation, crowding, or unstable water chemistry may respond poorly or develop complications. Merck recommends careful fish handling, protection of the skin and mucus coat, and close attention to dissolved oxygen, ammonia, and pH during procedures. (merckvetmanual.com)

Because hCG is injectable, dosing usually requires accurate body weight, reconstitution, injection-volume calculation, and safe restraint or sedation planning. Large volumes may need to be split between injection sites, and U.S. aquaculture guidance notes that chorionic gonadotropin is a prescription product restricted to use by or on the order of a licensed veterinarian. Pet parents should not try to estimate a dose from online forums or extrapolate from another fish species. (fws.gov)

Side effects in koi are often tied as much to handling and injection stress as to the hormone itself. After treatment, some fish may show temporary stress behaviors such as reduced appetite, hiding, increased opercular movement, or brief changes in swimming. Injection-site irritation, bruising, or tissue trauma can also occur, especially if restraint is difficult or the fish is large and active.

More serious concerns include failed response, rough spawning, secondary infection, or worsening stress in a debilitated fish. FDA information on indexed spawning aids for ornamental finfish notes that deaths associated with reproductive hormone use are uncommon, but when they happen they are often linked to secondary infections, rough handling, poor water quality, or use in weakened fish rather than the hormone alone. That is a practical reminder that the whole breeding setup matters. (fda.gov)

Contact your vet promptly if your koi develops severe lethargy, loss of balance, persistent abdominal swelling, heavy breathing, skin injury, bleeding, or does not recover normally after handling or sedation. In a pond setting, any post-procedure decline should also trigger an immediate check of temperature, dissolved oxygen, ammonia, nitrite, and pH, because environmental problems can quickly magnify medication-related stress. (merckvetmanual.com)

There is limited koi-specific published interaction data for hCG, so your vet will usually think in terms of the whole reproductive and procedural plan rather than a formal interaction chart. The biggest practical concerns are combining hormone treatment with other stressors at the same time, such as transport, aggressive handling, poor water quality, or sedation in a fish that is already unstable.

If your koi is receiving sedatives, anesthetics, antimicrobials, antiparasitics, or other reproductive hormones, tell your vet before treatment. Merck notes that fish procedures may involve anesthetic support and that water quality should be monitored closely during interventions. FDA also maintains specific legal pathways for fish drugs, and not every product marketed online for ornamental fish is legally available or appropriate. (merckvetmanual.com)

A useful rule for pet parents is this: do not mix hCG with other pond or injectable treatments unless your vet has reviewed the full plan. In some cases, your vet may prefer environmental correction first, a different spawning aid, or delaying treatment until the koi is in better condition. That kind of stepwise approach often lowers risk without closing off future options. (fda.gov)